Erythromycin-induced hearing loss.
Sacristán
J A
JA
Soto
J
J
de Cos
M A
MA
D004334:Drug Administration Schedule; D004917:Erythromycin / Q000008:administration & dosage / Q000009:adverse effects*; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D011358:Product Surveillance, Postmarketing
D004917:Erythromycin